JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2022-08-28 cq2019

投稿后，由with editor变成了Under Review，不知道是不是送审了的意思

299 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2020-03-11 454646258

刚修回去fangfang424 2020-02-08 发表::
454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表:
454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor

fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor

517 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2018-03-11 xiaobao111

8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！

1905 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2022-08-05 ms9000000283662601

偏重的研究方向：内分泌;临床内分泌
经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！

388 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2022-05-27 yolandanannan

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：Graves‘
经验分享：想问下接受到online时间多久？

327 0

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2021-12-29 MS54455111222

哪些期刊是公认的水刊？

1015 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

水刊真的不值得选择吗？什么情况下可选择水刊投稿？

846 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2020-06-06 373017227

18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？

1000 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2021-08-02 ms8000001335392378

请问这个杂志需要原始数据吗

759 0

[GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586362, encodeId=7caa5863629d, content=刚修回去fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 发表:: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222778, encodeId=e1ca1222e78d4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Graves‘ 经验分享：想问下接受到online时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9b55289175, createdName=yolandanannan, createdTime=Fri May 27 12:41:18 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092777, encodeId=15e01092e77c5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1015, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092778, encodeId=b0641092e78d5, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=846, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601616, encodeId=c00560161692, content=18天完成一审，建议转投endocrinology，拒稿都是建议转投吗？大家有这方面经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8d51490859, createdName=373017227, createdTime=Sat Jun 06 12:52:46 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004517, encodeId=2a28100451e88, content=请问这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=759, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4645542531, createdName=ms8000001335392378, createdTime=Mon Aug 02 02:30:57 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974840, encodeId=a03a9e484033, content=偏重的研究方向：临床 经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9dc5489083, createdName=ms4000000521026108, createdTime=Sat Jun 19 11:38:26 CST 2021, time=2021-06-19, status=1, ipAttribution=)]

2021-06-19 ms4000000521026108

偏重的研究方向：临床
经验分享：这个杂志要求上传supplementary data到数据库？请问这是要上传原始数据的意思吗

108 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务